Related references
Note: Only part of the references are listed.Prescribing opioids in older people
Allen R. Huang et al.
MATURITAS (2013)
BAYESIAN INFERENCE AND THE PARAMETRIC BOOTSTRAP
Bradley Efron
ANNALS OF APPLIED STATISTICS (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Genetically Polymorphic OCT1: Another Piece in the Puzzle of the Variable Pharmacokinetics and Pharmacodynamics of the Opioidergic Drug Tramadol
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Drug Delivery Trends in Clinical Trials and Translational Medicine: Evaluation of Pharmacokinetic Properties in Special Populations
Jenny Y. Chien et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Impaired Mobility, ASA Status and Administration of Tramadol are Risk Factors for Postoperative Delirium in Patients Aged 75 Years or More After Major Abdominal Surgery
Antoine Brouquet et al.
ANNALS OF SURGERY (2010)
Dose Proportionality of Once-Daily Trazodone Extended-Release Caplets Under Fasting Conditions
David Karhu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Comparative Pharmacokinetics of a Once-Daily Tramadol Extended-Release Tablet and an Immediate-Release Reference Product Following Single-Dose and Multiple-Dose Administration
David Karhu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Uptake/Efflux Transport of Tramadol Enantiomers and O-Desmethyl-Tramadol: Focus on P-Glycoprotein
Mouna Kanaan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management
Paul J. Jannetto et al.
PHARMACOGENOMICS (2009)
Ultra low-dose naloxone and tramadol/acetaminophen in elderly patients undergoing joint replacement surgery: A pilot study
Ngozi N. Imasogie et al.
PAIN RESEARCH & MANAGEMENT (2009)
Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)
Joseph Pergolizzi et al.
Pain Practice (2008)
Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain
Maria Luz G. Pascual et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Pharmacokinetics and dose proportionality of three tramadol Contramid® OAD tablet strengths
David Karhu et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2007)
Pharmacokinetic model and simulations of dose conversion from immediate- to extended-release tramadol
Bindu P. Murthy et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain
Andre D. Beaulieu et al.
CLINICAL THERAPEUTICS (2007)
Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol
Emilio Garcia Quetglas et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2007)
Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: A prospective, age-group-controlled study
Rudolf Likar et al.
CLINICAL THERAPEUTICS (2006)
Population pharmacokinetic/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics
Maria J. Garrido et al.
PHARMACEUTICAL RESEARCH (2006)
Comparative bioavailability between two tramadol once-daily oral formulations
C. Hernandez-Lopez et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2006)
Clinical pharmacology of tramadol
S Grond et al.
CLINICAL PHARMACOKINETICS (2004)
Training modalities: over-reaching and over-training in athletes, including a study of the role of hormones
M Hug et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Share Paper
